Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women
Paul M. Ridker, M. Vinayaga Moorthy, Nancy R. Cook, et al.
New England Journal of Medicine (2024)
Closed Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Lipoprotein(a) as a Pharmacological Target: Premises, Promises, and Prospects
Antonio Greco, Simone Finocchiaro, Marco Spagnolo, et al.
Circulation (2025) Vol. 151, Iss. 6, pp. 400-415
Closed Access | Times Cited: 1
Cutting-edge stroke prevention strategies
Lisa Kaindl, Julian Frederic Hotz, Julia Ferrari
eNeurologicalSci (2025) Vol. 39, pp. 100561-100561
Open Access | Times Cited: 1
Inflammation in atherosclerotic cardiovascular disease: From diagnosis to treatment
Natalie Arnold, Wolfgang Köenig
European Journal of Clinical Investigation (2025)
Open Access | Times Cited: 1
The Slow Progress in Developing Better Long-Term Cardiovascular Risk Assessment in Women Continues
Leslie J. Donato, Kyla Lara-Breitinger, Allan S. Jaffe
Clinical Chemistry (2025)
Closed Access
Biomarkers and 30-Year Cardiovascular Outcomes in Women
Chenlin Pei, Weishe Zhang, Jingrui Huang
New England Journal of Medicine (2025) Vol. 392, Iss. 8, pp. 827-828
Closed Access
Joint assessment of abdominal obesity and non-traditional lipid parameters for primary prevention of cardiometabolic multimorbidity: insights from the China health and retirement longitudinal study 2011–2018
Hurong Lai, Yansong Tu, Caifeng Liao, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Cardiometabolic index predicts cardiovascular events in aging population: a machine learning-based risk prediction framework from a large-scale longitudinal study
Yuan-Xi Luo, Zhiyang Yin, Lin Xin, et al.
Frontiers in Endocrinology (2025) Vol. 16
Open Access
Decreased plasma lipoxin A4, resolvin D1, protectin D1 are correlated with the complexity and prognosis of coronary heart disease: a retrospective cohort study
Yunfei Wang, Xue-tao Zhu, Ze-ping Hu
Prostaglandins & Other Lipid Mediators (2025), pp. 106990-106990
Closed Access
A Systematic Review and Meta-Analysis Association Between Periodontitis and Age-Related Macular Degeneration: Potential for Personalized Approach
Sophie Boberg-Ans, Frederikke Arnold-Vangsted, Anna Bonde Scheel-Bech, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 4, pp. 145-145
Open Access
Exploring neutrophils as therapeutic targets in cardiometabolic diseases
Mattia Albiero, Andrea Baragetti
Trends in Pharmacological Sciences (2025)
Closed Access
Kommentar zu „Biomarker zeigen prognostischen Wert bei kardiovaskulärer Primärprävention“

DMW - Deutsche Medizinische Wochenschrift (2025) Vol. 150, Iss. 04, pp. 126-127
Closed Access
Inflammation, Lp(a) and cardiovascular mortality: results from the LURIC study
Stephanie Wissel, Hubert Scharnagl, Marcus E. Kleber, et al.
Clinical Research in Cardiology (2025)
Closed Access
Can Lp(a) become the next A1C? A case for digital health management tools to overcome inertia to Lipoprotein (a) testing
Christof Wedemeyer, Martin Peters, Graham L. Jones
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
Lipoprotein(a) as a Causal Risk Factor for Cardiovascular Disease
Sean Doherty, Sebastian Hernandez, Rishi Rikhi, et al.
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Open Access
Women Under Pressure: Sex‐Specific Cardiovascular Consequences of Childhood Trauma in Black Adults
Katherine A. Maki, Nicole Farmer, Gwenyth R. Wallen
Journal of the American Heart Association (2025)
Open Access
Association between interleukin-6, suPAR, and hsCRP with subclinical left ventricular dysfunction in type 1 diabetes: The Thousand & 1 study
Hashmat Sayed Zohori Bahrami, Peter Godsk Jørgensen, Jens D. Hove, et al.
Diabetes Research and Clinical Practice (2025), pp. 112071-112071
Open Access
Systemic inflammation prevalence in patients with atherosclerotic cardiovascular disease and chronic kidney disease: a population-based study using a nationwide primary care database in Spain
Giancarlo Pesce, Gaëlle Gusto, Pierre Johansen, et al.
Frontiers in Cardiovascular Medicine (2025) Vol. 12
Open Access
The Impact of SNP Score on Low-Density Lipoprotein Cholesterol Concentration and Coronary Artery Disease
Darius Čereškevičius, Ieva Čiapienė, Ali Aldujeli, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2337-2337
Open Access
Comprehensive evaluation of siRNA therapeutics on Lp(a): A network meta‐analysis
Song Liu, Xingjin Wang, Jiaqiang Hu, et al.
Diabetes Obesity and Metabolism (2025)
Open Access
Inflammation in coronary atherosclerosis: diagnosis and treatment
Giovanni Occhipinti, Salvatore Brugaletta, Antonio Abbate, et al.
Heart (2025), pp. heartjnl-325408
Closed Access
Guidelines for the evolving landscape of liver disease: From viral hepatitis to MAFLD
Harendran Elangovan, Jacob George
Chinese Medical Journal (2025)
Open Access
Global Effect of Cardiovascular Risk Factors on Lifetime Estimates
Christina Magnussen, Jesús Alegre-Díaz, Lubna Alnasser, et al.
New England Journal of Medicine (2025)
Closed Access
LDL, Lp(a) und hsCRP reichen, um das kardiovaskuläre Risiko bei Frauen über die nächsten 30 Jahre zu umschreiben

Aktuelle Kardiologie (2025) Vol. 14, Iss. 02, pp. 94-94
Closed Access
Improved prediction and risk stratification of major adverse cardiovascular events using an explainable machine learning approach combining plasma biomarkers and traditional risk factors
Xi-Ru Zhang, Wen-Fang Zhong, Ruiyan Liu, et al.
Cardiovascular Diabetology (2025) Vol. 24, Iss. 1
Open Access
Impact of Lipid Lowering Therapies on the Primary Prevention of Atherosclerotic Cardiovascular Disease
AKRUTI P PRABHAKAR, Deepak Vedamurthy, Dinesh Kalra
Current Cardiovascular Risk Reports (2025) Vol. 19, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top